82 related articles for article (PubMed ID: 27924477)
21. Spatiotemporal control of microRNA function using light-activated antagomirs.
Connelly CM; Uprety R; Hemphill J; Deiters A
Mol Biosyst; 2012 Nov; 8(11):2987-93. PubMed ID: 22945263
[TBL] [Abstract][Full Text] [Related]
22. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis.
Cheng AM; Byrom MW; Shelton J; Ford LP
Nucleic Acids Res; 2005; 33(4):1290-7. PubMed ID: 15741182
[TBL] [Abstract][Full Text] [Related]
23. Faster experimental validation of microRNA targets using cold fusion cloning and a dual firefly-Renilla luciferase reporter assay.
Alvarez ML
Methods Mol Biol; 2014; 1182():227-43. PubMed ID: 25055916
[TBL] [Abstract][Full Text] [Related]
24. Clinical effects of miR-101 on prognosis of hepatocellular carcinoma and carcinogenic mechanism of anti-miR-101.
Lv X; Li J; Yang B
Oncol Rep; 2016 Oct; 36(4):2184-92. PubMed ID: 27498785
[TBL] [Abstract][Full Text] [Related]
25. Triplex-forming MicroRNAs form stable complexes with HIV-1 provirus and inhibit its replication.
Kanak M; Alseiari M; Balasubramanian P; Addanki K; Aggarwal M; Noorali S; Kalsum A; Mahalingam K; Pace G; Panasik N; Bagasra O
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):532-45. PubMed ID: 20502318
[TBL] [Abstract][Full Text] [Related]
26. MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling.
Mao Y; Wu S; Zhao R; Deng Q
J Int Med Res; 2016 Apr; 44(2):231-40. PubMed ID: 26880795
[TBL] [Abstract][Full Text] [Related]
27. Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus.
Jimenez-Mateos EM; Engel T; Merino-Serrais P; Fernaud-Espinosa I; Rodriguez-Alvarez N; Reynolds J; Reschke CR; Conroy RM; McKiernan RC; deFelipe J; Henshall DC
Brain Struct Funct; 2015 Jul; 220(4):2387-99. PubMed ID: 24874920
[TBL] [Abstract][Full Text] [Related]
28. NF-κB target microRNAs and their target genes in TNFα-stimulated HeLa cells.
Zhou F; Wang W; Xing Y; Wang T; Xu X; Wang J
Biochim Biophys Acta; 2014; 1839(4):344-54. PubMed ID: 24418602
[TBL] [Abstract][Full Text] [Related]
29. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of novel microRNA candidates from deep sequencing.
Wu Q; Wang C; Guo L; Ge Q; Lu Z
Clin Chim Acta; 2013 Jan; 415():239-44. PubMed ID: 23153516
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA expression profiles of porcine skeletal muscle.
Zhou B; Liu HL; Shi FX; Wang JY
Anim Genet; 2010 Oct; 41(5):499-508. PubMed ID: 20331612
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
Hartmann D; Fiedler J; Sonnenschein K; Just A; Pfanne A; Zimmer K; Remke J; Foinquinos A; Butzlaff M; Schimmel K; Maegdefessel L; Hilfiker-Kleiner D; Lachmann N; Schober A; Froese N; Heineke J; Bauersachs J; Batkai S; Thum T
Circulation; 2016 Dec; 134(24):1973-1990. PubMed ID: 27780851
[TBL] [Abstract][Full Text] [Related]
33. Targeting respiratory diseases using miRNA inhibitor based nanotherapeutics: Current status and future perspectives.
Mehta M; Satija S; Paudel KR; Malyla V; Kannaujiya VK; Chellappan DK; Bebawy M; Hansbro PM; Wich PR; Dua K
Nanomedicine; 2021 Jan; 31():102303. PubMed ID: 32980549
[TBL] [Abstract][Full Text] [Related]
34. Multifunctional Nanoparticles Facilitate Molecular Targeting and miRNA Delivery to Inhibit Atherosclerosis in ApoE(-/-) Mice.
Kheirolomoom A; Kim CW; Seo JW; Kumar S; Son DJ; Gagnon MK; Ingham ES; Ferrara KW; Jo H
ACS Nano; 2015 Sep; 9(9):8885-97. PubMed ID: 26308181
[TBL] [Abstract][Full Text] [Related]
35. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
[TBL] [Abstract][Full Text] [Related]
36. Quantification of Oligonucleotide Association with miRNA-Argonaute Complexes In Vitro.
Zisoulis DG
Methods Mol Biol; 2017; 1517():71-78. PubMed ID: 27924474
[TBL] [Abstract][Full Text] [Related]
37. [Expression of microRNAs in lung homogenates in rats with chronic obstructive pulmonary disease].
Li B; Zhou X; Chen L; Feng C; Li T
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Dec; 26(12):905-9. PubMed ID: 25476085
[TBL] [Abstract][Full Text] [Related]
38. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
39. Quantification of microRNA in plasma using probe based TaqMan assays: is microRNA purification required?
Binderup HG; Madsen JS; Brasen CL; Houlind K; Andersen RF
BMC Res Notes; 2019 May; 12(1):261. PubMed ID: 31077242
[TBL] [Abstract][Full Text] [Related]
40. Strategies to identify microRNA targets: new advances.
Jin H; Tuo W; Lian H; Liu Q; Zhu XQ; Gao H
N Biotechnol; 2010 Dec; 27(6):734-8. PubMed ID: 20888440
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
